Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Apr-24 4:39 PM View:  | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Apr-24 | Payment of Exercise | 1,736 | $115.21 | $200,005.00 | (3%) 57.09K to 55.36K | |
| 07-Mar-24 9:53 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Mar-24 | Payment of Exercise | 3,622 | $117.53 | $425,694.00 | (6%) 60.72K to 57.09K | |
| 05-Mar-24 7:44 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 01-Mar-24 | Grant | 19,916 | -- | -- | 49% 40.8K to 60.72K | |
| 19-Jan-24 6:23 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Grant | 7,079 | -- | -- | 19% 36.92K to 44.0K | |
| 19-Jan-24 6:23 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 17-Jan-24 | Payment of Exercise | 3,204 | $119.13 | $381,692.00 | (7%) 44.0K to 40.8K | |
| 14-Nov-23 10:00 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 10-Nov-23 | Grant | 772 | -- | -- | 2% 36.12K to 36.89K | |
| 19-May-23 8:45 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 18-May-23 | Market Sale | 6,000 | $131.75 | $790,474.00 | (14%) 41.98K to 35.98K | (11%) |
| 07-Apr-23 5:44 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Apr-23 | Payment of Exercise | 1,807 | $145.78 | $263,424.00 | (4%) 43.78K to 41.98K | (< 1%) |
| 07-Mar-23 9:14 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Mar-23 | Payment of Exercise | 1,557 | $142.78 | $222,308.00 | (3%) 45.34K to 43.78K | |
| 07-Mar-23 9:14 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 03-Mar-23 | Grant | 12,784 | -- | -- | 39% 32.56K to 45.34K | |
| 22-Dec-22 4:53 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 21-Dec-22 | Private Sale (Planned) | 2,635 | $160.00 | $421,600.00 | (7%) 35.19K to 32.56K | |
| 07-Apr-22 4:17 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Apr-22 | Payment of Exercise | 1,633 | $162.88 | $265,983.00 | (4%) 36.63K to 34.99K | |
| 09-Mar-22 5:53 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Mar-22 | Disposition | 720 | $153.96 | $110,851.00 | (2%) 37.35K to 36.63K | |
| 09-Mar-22 5:53 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 03-Mar-22 | Grant | 11,730 | -- | -- | 46% 25.62K to 37.35K | |
| 07-Apr-21 5:32 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 05-Apr-21 | Payment of Exercise | 1,515 | $164.71 | $249,536.00 | (6%) 26.86K to 25.35K | 1% |
| 01-Mar-21 5:51 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 25-Feb-21 | Grant | 10,115 | -- | -- | 60% 16.75K to 26.86K | |
| 11-May-20 5:05 PM View: | Jazz Pharmaceuticals, Inc. (JAZZ) | 07-May-20 | Grant | 16,600 | -- | -- | 100% 0 to 16.6K | |
| 21-Nov-18 5:42 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-18 | Payment of Exercise | 6,697 | $24.79 | $166,019.00 | (4%) 164.35K to 157.66K | |
| 22-Aug-18 7:32 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-18 | Payment of Exercise | 6,695 | $26.95 | $180,430.00 | (4%) 171.05K to 164.35K | |
| 16-Aug-18 7:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 15-Aug-18 | Sale | 41,539 | $26.74 | $1,110,660.00 | (20%) 212.59K to 171.05K | |
| 16-Aug-18 7:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-Aug-18 | Sale | 2,204 | $27.74 | $61,135.90 | (1%) 214.79K to 212.59K | |
| 22-May-18 7:01 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-18 | Payment of Exercise | 21,230 | $24.31 | $516,101.00 | (9%) 236.02K to 214.79K | |
| 22-May-18 7:01 PM View: | Theravance Biopharma, Inc. (TBPH) | 18-May-18 | Sale | 10,000 | $24.29 | $242,877.00 | (4%) 246.02K to 236.02K | |
| 16-May-18 7:03 PM View: | Theravance Biopharma, Inc. (TBPH) | 14-May-18 | Grant | 33,750 | -- | -- | 16% 212.27K to 246.02K | |
| 07-Mar-18 8:38 PM View: | Corcept Therapeutics Inc. (CORT) | 07-Mar-18 | Market Purchase | 9,000 | $15.53 | $139,802.00 | 900% 1.0K to 10.0K | 81% |
| 07-Mar-18 8:38 PM View: | Corcept Therapeutics Inc. (CORT) | 06-Mar-18 | Market Purchase | 1,000 | $15.30 | $15,300.00 | 100% 0 to 1.0K | 83% |
| 22-Feb-18 5:38 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-18 | Payment of Exercise | 5,387 | $29.09 | $156,708.00 | (2%) 216.79K to 211.41K | |
| 14-Feb-18 6:19 PM View: | Theravance Biopharma, Inc. (TBPH) | 12-Feb-18 | Grant | 9,000 | -- | -- | 4% 207.79K to 216.79K | |
| 22-Nov-17 4:35 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-17 | Payment of Exercise | 6,753 | $28.58 | $193,001.00 | (3%) 214.55K to 207.79K | |
| 22-Aug-17 6:27 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-17 | Payment of Exercise | 6,752 | $27.40 | $185,005.00 | (3%) 221.3K to 214.55K | |
| 23-May-17 7:58 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-17 | Payment of Exercise | 6,753 | $36.83 | $248,713.00 | (3%) 228.05K to 221.3K | |
| 22-Feb-17 7:05 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-17 | Payment of Exercise | 10,211 | $33.78 | $344,928.00 | (4%) 236.56K to 226.35K | |
| 08-Feb-17 7:05 PM View: | Theravance Biopharma, Inc. (TBPH) | 06-Feb-17 | Grant | 9,000 | -- | -- | 4% 227.56K to 236.56K | |
| 22-Nov-16 6:01 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Nov-16 | Payment of Exercise | 4,628 | $31.96 | $147,911.00 | (2%) 232.19K to 227.56K | |
| 23-Aug-16 7:22 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-16 | Payment of Exercise | 4,306 | $27.89 | $120,094.00 | (2%) 236.5K to 232.19K | |
| 24-May-16 7:58 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-May-16 | Payment of Exercise | 3,333 | $20.55 | $68,493.10 | (1%) 239.83K to 236.5K | |
| 17-Mar-16 7:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 15-Mar-16 | Grant | 90,000 | -- | -- | 61% 148.13K to 238.13K | |
| 23-Feb-16 7:58 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Feb-16 | Payment of Exercise | 13,052 | $15.65 | $204,264.00 | (8%) 161.18K to 148.13K | |
| 17-Aug-15 7:21 PM View: | Theravance Biopharma, Inc. (TBPH) | 17-Aug-15 | Purchase | 5,000 | $12.16 | $60,800.00 | 3% 156.18K to 161.18K | |
| 17-Aug-15 7:21 PM View: | Theravance Biopharma, Inc. (TBPH) | 13-Aug-15 | Purchase | 5,000 | $12.19 | $60,950.00 | 3% 149.28K to 154.28K | |
| 09-Feb-15 8:08 PM View: | Theravance Biopharma, Inc. (TBPH) | 05-Feb-15 | Grant | 135,000 | -- | -- | 945% 14.28K to 149.28K | |
| 22-Aug-14 5:01 PM View: | Theravance Biopharma, Inc. (TBPH) | 20-Aug-14 | Payment of Exercise | 158 | $26.98 | $4,262.84 | (1%) 14.44K to 14.28K |